Insulin-like growth factor II receptor Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	Mannose 6-phosphate	IC50	11500.0 [1]
	beta-D-Glucose-6-phosphate	IC50	10000.0 [1]
	(Z)-3-(3-Iodo-4-phenoxyphenyl)-2-pyridin-2-ylprop-2-enenitrile	IC50	46500.0 [1]
	[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[(2R,3S)-3-Acetamido-4-[[(2S)-6-[(2-aminobenzoyl)amino]-1-[[(2S,3R)-1-amino-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphate	IC50	90.0 [1]
	(Z)-3-(4-Hydroxyphenyl)-2-pyridin-2-ylprop-2-enenitrile	IC50	77100.0 [1]
	(Z)-3-(4-Hydroxy-3-methoxyphenyl)-2-pyridin-2-ylprop-2-enenitrile	IC50	3200.0 [1]
	[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[(2R,3S)-3-Acetamido-4-[[(2S)-6-amino-1-[[(2S,3R)-1-amino-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphate	IC50	20000.0 [1]
	[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[(2R,3S)-3-Acetamido-4-[[(2S)-6-acetamido-1-[[(2S,3R)-1-amino-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphate	IC50	1800.0 [1]
	Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[12-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxydodecoxy]oxan-2-yl]methyl dihydrogen phosphate	IC50	3700.0 [1]
	Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[10-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxydecoxy]oxan-2-yl]methyl dihydrogen phosphate	IC50	4440.0 [1]
	Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[8-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoctoxy]oxan-2-yl]methyl dihydrogen phosphate	IC50	5030.0 [1]
	Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[6-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyhexoxy]oxan-2-yl]methyl dihydrogen phosphate	IC50	4760.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 12 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Insulin-like growth factor II receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/insulin-like-growth-factor-ii-receptor-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 9). Quest Database™ Insulin-like growth factor II receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/insulin-like-growth-factor-ii-receptor-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan